Project Grant R01AR083790
Award Date
8/22/24
Completion Date
7/31/29
Dollars Obligated
$360K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Chapel Hill, NC 27599, USA
Similar Awards
This $718,693 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support a collaborative research project between Henry Ford Health and Michigan State University Health Sciences to conduct whole-genome sequencing analysis of Hidradenitis Suppurativa (HS). The key objectives are to: 1) Perform whole-genome sequencing analysis to identify...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the role of gamma secretase (GS) activity and regulation of the NCSTN protein in hidradenitis suppurativa (HS), a chronic inflammatory skin disease. The $161,922 award to The Johns Hopkins University will fund studies to characterize GS enzymatic activity and NCSTN expression in HS patient...
This federal Project Grant award of $466,198, awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research into the role of cortisol synthesis in the pathogenesis of intradermal tunnels associated with hidradenitis suppurativa (HS), a common and debilitating inflammatory skin disease. The key products and services to be delivered under this grant include:...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $502,031 to Emory University to conduct research on the potential link between Epstein-Barr virus (EBV) and Hidradenitis Suppurativa (HS), a chronic inflammatory skin condition. The project aims to (1) determine the clonal dynamics of B cells and plasma cells in HS skin lesions, (2) recreate human monoclonal...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $198,782.00 to Duke University to develop 3D human reconstructed epidermis (RHE) cultures with CRISPR/Cas9 gene knockouts. The goal is to enable investigation of interactions between the skin microbiome and skin cell populations. The RHE cultures will be colonized with commensal and...
This Project Grant award of $649,391, awarded on May 12, 2025 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), supports research to enhance healing after injury. The research, conducted by The Johns Hopkins University, aims to define the mechanisms that restrain healing in epithelial tissues like skin and gut, with the goal of developing new therapies to improve regeneration following diverse injuries or infections. The work is funded through the NIAMS...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $343,904 to The Regents of the University of California, San Francisco to investigate transcriptional abnormalities in skin-resident T cells as potential biomarkers for atopic dermatitis in Asian and Hispanic genetic backgrounds. The research aims to validate an abnormal atopic T...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $599,693 to The Hospital For Special Surgery Fund, Inc. (HSS Foundation) from August 1, 2024 to July 31, 2029. The award supports research to elucidate molecular pathways and mechanisms that regulate myeloid cell function and osteoclastogenesis, with the goal of developing new...
This federal Project Grant award, valued at $230,212 and provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), supports research under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The goal of the research is to investigate how the immune system, specifically dendritic epidermal T cells (DETCs), drives functional heterogeneity in skin epithelial stem cells within and across different niches. The research will shed...
This federal Project Grant award for $113,090.00, provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), supports research at the University of Pittsburgh to investigate the epigenetic regulatory networks driving increased expression of TGF-β3 in systemic sclerosis (SSc) skin myofibroblasts. The central objective is to determine the role of TGF-β3 and its regulator...